Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]

ASH 2015: Ibrutinib as first-line treatment for chronic lymphocytic leukaemia

Prof John Gribben and Prof Stilgenbauer

ASH 2015: Ibrutinib as first-line treatment for chronic lymphocytic leukaemia ( Prof John Gribben and Prof Stilgenbauer )

ASH 2015: New targeted therapies for haematological malignancies

Dr Robert Hromas - University of Florida, Gainesville, USA

ASH 2015: New targeted therapies for haematological malignancies ( Dr Robert Hromas - University of Florida, Gainesville, USA )

Combination therapy with idelalisib better prevents disease progression in...

Dr Andrew D. Zelenetz - Memorial Sloan Kettering Cancer Center, New York, USA

Combination therapy with idelalisib better prevents disease progression in relapsed or treatment-resistant chronic lymphocytic leukaemia than current regimen ( Dr Andrew D. Zelenetz - Memorial Sloan Kettering Cancer Center, New York, USA )

First targeted therapy for multiple myeloma effective against hard-to-treat...

Dr Torben Plesner - Vejle Hospital, University of Southern Denmark, Vejle...

First targeted therapy for multiple myeloma effective against hard-to-treat disease ( Dr Torben Plesner - Vejle Hospital, University of Southern Denmark, Vejle, Denmark )

First targeted therapy for genetically defined subset of patients with acute...

Dr Richard M. Stone - Dana-Farber Cancer Institute, Boston, USA

First targeted therapy for genetically defined subset of patients with acute myeloid leukaemia significantly improves survival ( Dr Richard M. Stone - Dana-Farber Cancer Institute, Boston, USA )

Study finds new use for rituximab in acute lymphoblastic leukaemia

Prof Sébastien Maury - Hôpital Henri Mondor, Créteil, France

Study finds new use for rituximab in acute lymphoblastic leukaemia ( Prof Sébastien Maury - Hôpital Henri Mondor, Créteil, France )

Immunotherapy makes patients’ tumours "melt away"

Dr Joshua Brody - Mount Sinai Medical Center, New York, USA

Immunotherapy makes patients’ tumours "melt away" ( Dr Joshua Brody - Mount Sinai Medical Center, New York, USA )

ASH 2015: Monoclonal antibodies for multiple myeloma

Dr Saad Usmani and Prof Thierry Facon

ASH 2015: Monoclonal antibodies for multiple myeloma ( Dr Saad Usmani and Prof Thierry Facon )

Daratumumab for multiple myeloma

Prof Sagar Lonial - Emory University School of Medicine, Atlanta, USA

Daratumumab for multiple myeloma ( Prof Sagar Lonial - Emory University School of Medicine, Atlanta, USA )

Engineered cells to target multiple myeloma

Dr James Kochenderfer - National Cancer Institute, Bethesda, USA

Engineered cells to target multiple myeloma ( Dr James Kochenderfer - National Cancer Institute, Bethesda, USA )

Cancer Core Europe: where did it come from and what is its future?

Prof Julio Celis - Danish Cancer Society Research Center, Copenhagen, Denmark

Cancer Core Europe: where did it come from and what is its future? ( Prof Julio Celis - Danish Cancer Society Research Center, Copenhagen, Denmark )

Highlights of the EurocanPlatform Project

Highlights of the EurocanPlatform Project ( )

More from ecancer